About ArtiQ
ArtiQ is a Healthcare company based in Leuven (Belgium) founded in 2019 by Marc Decramer, wim janssens, Marko Topalovic, and Bart Swaelens, and was acquired by Clario in April 2024. AI-powered software to optimize clinical trials and enhance diagnostic processes. ArtiQ has raised $1.12 million across 2 funding rounds from investors including KU Leuven, EIT Health and Clario. The company has 9 employees. Its chief executive, as recorded, is Marko Topalovic. ArtiQ offers products and services including ArtiQ.PFT, ArtiQ.QC, ArtiQ.RBM, and ArtiQ.Spiro. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ArtiQ NV.
Company details
Founded in 2019 and based in Leuven, Belgium, ArtiQ operates in the health technology sector. A cloud-based AI platform is developed to interpret pulmonary function test data alongside patient medical records. Clinical insights into lung disorders are generated, diagnostic solutions are provided, and reports are documented in electronic health records. Recommendations for treatment planning are also offered to support healthcare processes.
Products & Services of ArtiQ
ArtiQ offers a comprehensive portfolio of products and services, including ArtiQ.PFT, ArtiQ.QC, ArtiQ.RBM, and ArtiQ.Spiro.
AI-supported tool for interpreting pulmonary function tests.
Automates evaluation of spirometry data quality.
Provides AI-based risk monitoring for clinical trials.
Offers automated support for spirometry test analysis.
Funding Insights of ArtiQ
ArtiQ has successfully raised a total of $1.12M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $56.43 thousand completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.12M
- Total Rounds 2
- Last Round Grant — $56,425
- First Round $1.12M
(Jun 2019)
- Investors Count 3
All 2 funding rounds of ArtiQ with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2019 | $56,425 | Grant | – | – | |
| Jun 2019 | $1.12M | Seed | – | KBC Focus Fund, KU Leuven | – |
4 investors in total: 4 institutional.
Investors in ArtiQ
ArtiQ has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include KU Leuven, EIT Health and Clario.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
| focusfund.be | ||||
Higher education is delivered through diverse courses and degrees. | 1425 | kuleuven.be | Leuven, Belgium | |
CRO focused on providing clinical trial supply services for biopharma sector | 1972 | clario.com | Philadelphia, United States |
Investor details for ArtiQ
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ArtiQ
8 people are tracked at ArtiQ (5 in leadership, 1 in board & advisors, 2 in team); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Marc Decramer | Co-Founder | Leadership |
wim janssens | Co-Founder | Leadership |
Marko Topalovic | Co-Founder & CEO | Leadership |
Bart Swaelens | Co-Founder | Leadership |
Valerie Hemberg | COO & CFO | Leadership |
Maarten De Vos | R&D Advisor | Board & advisors |
Yuri Van Havere | Technical Product Manager | Team |
Nele Gregoor | Admin Support | Team |
Complete people profiles for ArtiQ
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ArtiQ
4 dated milestones of ArtiQ across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ArtiQ is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Grant, of $56K.
- Exit Acquired by Clario.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Artiq
Complete news archive for ArtiQ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ArtiQ
ArtiQ was founded in 2019.
ArtiQ is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Marko Topalovic is the CEO of ArtiQ, as recorded in our data. They have also founded this company.
ArtiQ is a funded company, having raised a total of $1.12M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.12M, raised on Jun 2019.
ArtiQ has 9 employees.
Founded in 2019 and based in Leuven, Belgium, ArtiQ operates in the health technology sector. A cloud-based AI platform is developed to interpret pulmonary function test data alongside patient medical records. Clinical insights into lung disorders are generated, diagnostic solutions are provided, and reports are documented in electronic health records. Recommendations for treatment planning are also offered to support healthcare processes.
ArtiQ offers ArtiQ.PFT, ArtiQ.QC, ArtiQ.RBM, and ArtiQ.Spiro.
ArtiQ has 4 investors. Key investors include KU Leuven, EIT Health, Clario, and KBC Focus Fund.
ArtiQ operates through Artiq Nv.
Yes. ArtiQ was acquired by Clario in April 2024.